Is there a philosophical nationalism? Reading Fichte’s Addresses to the German Nation and its use by the Nazis, Derrida concluded that all nationalisms are philosophical and onto-theological as they are posited beyond race, biology, and nature. However, Fichte’s text reveals a specific form of racism that insists on biology and nature. Fichte’s racism is a species of “hypophysics,” a consecration of nature as value. His theory of language is simultaneously biological and spiritual, these two aspects flowing from a single geistige (...) Naturgesetz (spiritual-natural-law) and determining the hypophysical unity of language, community and “philosophy” (as he defined it). The logic of such a hypophysics is misrecognized and left unaddressed in the conventional categories of “naturalism” and “biologism.” Further, hypophysical-logic is not onto-theo-logic (in Heidegger’s definition). This imposes new questions for the history and future of philosophy: how does hypophysics enter philosophy; can there be philosophy without hypophysics and its attendant racisms? (shrink)

Psychoanalysis cannot be excluded from questions of psyche, health, and society in medical care and medical ethics. But can psychoanalysis be conceived as a therapeutic possibility beyond Europe? The ethics of thinking psychoanalysis beyond Europe must first confront the abnegated cartography of Europe and its beyond and do so without confining itself to the colonial moment. It must also confront the politics of the circuits that psychoanalysis has already inhabited. Such an ethic must confront caste as the continent—to indulge in (...) the old witz—neither dark nor unconscious and yet hidden in plain sight both in Indian and European psychoanalysis. Unlike the unnameable Latin America that Derrida felt compelled in 1981 to name within psychoanalysis in the name of ethics, we will have to confront the politics of other hidden names—India, Orient, “Aryan”—that swarm around this unnamed “caste” in the history, and possibly the future, of psychoanalysis. (shrink)

Global Dental Practice Management Software Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Major Companies Focus on Partnerships to Leverage Enhanced Solutions -/- In terms of the competitive landscape, the dental practice management software market has a partial consolidation owing to the large shares held by leading companies. Different strategic moves, including joint ventures, mergers, and acquisitions are being leveraged (...) by prominent companies to reinforce their industry position. A wide array of players are focusing on partnerships to deploy enhanced solutions. -/- Drivers & Restraints -/- The global dental practice management software market size was valued at USD 1.65 billion in 2023. The market is expected to expand from USD 1.80 billion in 2024 to USD 3.90 billion by 2032, exhibiting a CAGR of 10.2% over the study period. -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Dental Practice Management Software Market report. -/- This report focuses on Dental Practice Management Software Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Dental Practice Management Software Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Dental Practice Management Software Market research report: -/- NXGN Management, LLC (U.S.) Planet DDS (U.S.) ACE Dental Software (U.S.) Datacon Dental Systems (U.S.) Good Methods Global Inc. (U.S.) CD Newco, LLC (U.S.) Henry Schein, Inc (U.S.) Carestream Dental LLC (U.S.) DentiMax (U.S.). (shrink)

Global Medical Robotic Systems Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Get a Sample Copy of the Report at – -/- Robots used in the medical industry, ranging for various applications surgical interventions to rehabilitation are known as medical robots. The ever increasing efficiency of these robots in performing tasks which include surgeries have been pivotal in the rapid (...) adoption of these robots in the medical industry. -/- Drivers & Restraints -/- The global medical robotic systems market size stood at USD 2,257.8 Million in 2018 and is projected to reach USD 10,710.6 Million in 2026, exhibiting at a CAGR of 21.5% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Medical Robotic Systems Market report. -/- This report focuses on Medical Robotic Systems Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Medical Robotic Systems Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Medical Robotic Systems Market research report: -/- Ekso Bionics Intuitive Surgical Inc. Medtronic Stryker CYBERDYNE INC. BIONIK Smith & Nephew Zimmer Biomet Other Prominent Players. (shrink)

Global Transcatheter Heart Valve Replacement Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- The global transcatheter heart valve replacement (THVR) market size was USD 4.04 billion in 2018 and is projected to reach USD 10.34 billion by 2026, exhibiting a CAGR of 12.5% during the forecast period. -/- Drivers & Restraints -/- The global transcatheter heart valve replacement market size (...) stood at USD 4.04 Billion in 2018 and is projected to reach USD 10.34 Billion by 2026, exhibiting at a CAGR of 12.5% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Transcatheter Heart Valve Replacement Market report. -/- This report focuses on Transcatheter Heart Valve Replacement Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Transcatheter Heart Valve Replacement Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Transcatheter Heart Valve Replacement Market research report: -/- Edwards Lifesciences Corporation Abbott Medtronic LivaNova PLC Boston Scientific Corporation CryoLife, Inc. Micro Interventional Devices, Inc. (shrink)

The global “diabetes monitoring devices market size” is expected to rise owing to increasing awareness about the self-management of diabetes. Fortune Business Insights in a report, titled “Diabetes Monitoring Devices: Global Market Analysis, Insights and Forecast, 2019-2026” offers valuable insights into the market, highlighting opportunities and threats alike. The global market is expected to yield huge profits facilitated by remarkable developments in diabetes management. As per the International Diabetes Foundation (IDF), the number of people suffering from diabetes was 415 million (...) in 2015 and is expected to reach 642 million by the year 2040. The rising prevalence of diabetes across the globe is a major factor driving the market. (shrink)

Global Microfluidic Devices Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Methods of performing experiments easily, cheaply, and speedily, as well as in a highly sensitive and throughput manner, are desirable for many scientific endeavors and commercial applications. To achieve this, the USA introduced the microarray and microfluidic technologies that are beneficial for the discovery of new drugs and analysis (...) of biological systems. -/- Drivers & Restraints -/- The global microfluidic devices market size stood at USD 5.14 Billion in 2018 and is projected to reach USD 22.65 Billion by 2026, exhibiting at a CAGR of 20.5% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Microfluidic Devices Market report. -/- This report focuses on Microfluidic Devices Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Microfluidic Devices Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Microfluidic Devices Market research report: -/- uFluidix Perkin Elmer Fluidigm Blacktrace Holdings Ltd. (Dolomite Microfluidic) Micronit BioFluidix GmbH‎ Fluigent ALine, Inc. Philips Other prominent players. (shrink)

The authors of this insightful and urgent collection both use the metaphor of evil as a virus or contagion and conceptualize the COVID-19 virus as a manifestation of evil to reconsider the purpose of philosophy in and for a pandemic.

Global Women's Health Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- The global women’s health market size was valued at USD 35.02 billion in 2019 and is projected to reach USD 41.05 billion by 2027, exhibiting a CAGR of 3.2% during the forecast period. -/- Drivers & Restraints -/- The global women's health market size stood at USD 35.02 Billion (...) in 2019 and is projected to reach USD 41.05 Billion by 2027, exhibiting at a CAGR of 3.2% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Women's Health Market report. -/- This report focuses on Women's Health Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Women's Health Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Women's Health Market research report: -/- Bayer AG (Leverkusen, Germany) Pfizer Inc. (New York, United States) Amgen Inc. (California, United States) Novartis AG (Basel, Switzerland) Merck & Co., Inc. (New Jersey, United States) Eli Lilly and Company (Indiana, United States) LUPIN (Mumbai, India) AstraZeneca (Cambridge, United Kingdom) Agile Therapeutics (New Jersey, United States) . (shrink)

Global Biopharmaceuticals Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Biopharmaceuticals are complex medicines extracted or semisynthesized from biological sources using biotechnological methods. They can be sugars, proteins, nucleic acids, living cells, or tissues used for therapeutic or in vivo diagnostic purposes and are produced by means other than direct extraction from a native or non-engineered biological source. -/- Drivers (...) & Restraints -/- The global biopharmaceuticals market size stood at USD 470.80 Billion in 2023 and is projected to reach USD 799.76 Billion by 2030, exhibiting at a CAGR of 7.9% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Biopharmaceuticals Market report. -/- This report focuses on Biopharmaceuticals Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Biopharmaceuticals Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. (shrink)

The accuracy of cell division requires precise regulation of the cellular machinery governing DNA/genome duplication, ensuring its equal distribution among the daughter cells. The control of the centrosome cycle is crucial for the formation of a bipolar spindle, ensuring error‐free segregation of the genome. The cell and centrosome cycles operate in close synchrony along similar principles. Both require a single duplication round in every cell cycle, and both are controlled by the activity of key protein kinases. Nevertheless, our comprehension of (...) the precise cellular mechanisms and critical regulators synchronizing these two cycles remains poorly defined. Here, we present our hypothesis that the spatiotemporal regulation of a dynamic equilibrium of mitotic kinases activities forms a molecular clock that governs the synchronous progression of both the cell and the centrosome cycles. (shrink)

Global Digital Health Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Get a Sample Copy of the Report at – -/- The global digital health market size was valued at USD 548.08 billion in 2021 and is projected to grow from USD 742.72 billion in 2022 to USD 4,547.70 billion by 2029, exhibiting a CAGR of 29.5% during the forecast (...) period. Based on our analysis, the global market exhibited a higher growth of 81.2% in 2020 compared to 2019. The global COVID-19 pandemic has been unprecedented and staggering, with digital health experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. -/- Drivers & Restraints -/- The global digital health market size stood at USD 452.79 Billion in 2023 and is projected to reach USD 1,965.30 Billion by 2030, exhibiting at a CAGR of 23.3% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Digital Health Market report. -/- This report focuses on Digital Health Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Digital Health Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Digital Health Market research report: -/- General Electric Company (U.S.) Koninklijke Philips N.V. (Netherlands) Allscripts Healthcare, LLC (U.S.) Cerner Corporation (U.S.) Epic Systems Corporation (U.S.) McKesson Corporation (U.S.) Medical Information Technology, Inc. (U.S.) Siemens Healthcare GmbH (Germany) Boston Scientific Corporation (U.S.) FUJIFILM Holdings Corporation (Japan) Medtronic (Ireland) IBM (U.S.) Validic (U.S.). (shrink)

Global In-vitro Diagnostics Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Get a Sample Copy of the Report at – -/- In vitro Diagnostics (IVD) are medical devices used to perform diagnostic tests on biological samples such as blood, urine, and tissues. The IVD tests help detect and monitor infectious diseases, autoimmune diseases, and several medical conditions that are being (...) used to analyze drug therapies. Furthermore, according to the British In-vitro Diagnostic Association, in vitro diagnostics tests influence approximately 70% of clinical decisions. However, less than 1% of the NHS's budget is spent developing innovative IVD product portfolios each year. -/- Drivers & Restraints -/- The global in-vitro diagnostics market size stood at USD 97.12 Billion in 2023 and is projected to reach USD 157.02 Billion by 2030, exhibiting at a CAGR of 7.1% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this In-vitro Diagnostics Market report. -/- This report focuses on In-vitro Diagnostics Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall In-vitro Diagnostics Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global In-vitro Diagnostics Market research report: -/- F. Hoffmann-La Roche Ltd (Switzerland) Abbott Laboratories (U.S.) Thermo Fisher Scientific Inc. (U.S.) Sysmex Corporation (Japan) Siemens Healthineers AG (Germany) BD (Becton, Dickinson, and Company) (U.S.) Seegene Inc. (Republic of Korea) DiaSorin S.p.A. (Italy) Quest Diagnostics Incorporated (U.S.) Bio-Rad Laboratories, Inc. (U.S.). (shrink)

L'œuvre singulière plurielle de Jean-Luc Nancy a croisé presque toutes les préoccupations majeures de la philosophie - temps, être, espace, négativité, forme, image, poésie -, et a exercé une influence considérable sur de nombreux intellectuels et chercheurs du monde entier. Dans cet ouvrage, qui rassemble des articles rédigés par des philosophes et spécialistes reconnus, français et étrangers (Europe, Inde, États-Unis, Japon, Brésil, Chili, Égypte), les auteurs rendent hommage à Nancy pour son amitié et sa pensée. Considérant qu'une histoire particulière de (...) la philosophie a pris fin, Nancy a montré que la philosophie peut se lever à nouveau, touchant à son éternité. Il a invité à la recommencer de manière multiple, métaphysique, post-phénoménologique, politique, littéraire et esthétique. Se souvenir de sa pensée, c'est donc recommencer ici d'une manière plurielle avec lui?; c'est relancer dans son sillage la réflexion sur la démocratie et l'art, en réassumant une approche résolument transversale, avec ce que Nancy appelait anastasis - ce qui "ne provient pas de soi" mais "vient de l'autre, ou relève de l'autre en lui?"--Back cover. (shrink)

Global Transcatheter Heart Valve Replacement Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- The global transcatheter heart valve replacement (THVR) market size was USD 4.04 billion in 2018 and is projected to reach USD 10.34 billion by 2026, exhibiting a CAGR of 12.5% during the forecast period. -/- Drivers & Restraints -/- The global transcatheter heart valve replacement market size (...) stood at USD 4.04 Billion in 2018 and is projected to reach USD 10.34 Billion by 2026, exhibiting at a CAGR of 12.5% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Transcatheter Heart Valve Replacement Market report. -/- This report focuses on Transcatheter Heart Valve Replacement Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Transcatheter Heart Valve Replacement Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Transcatheter Heart Valve Replacement Market research report: -/- Edwards Lifesciences Corporation Abbott Medtronic LivaNova PLC Boston Scientific Corporation CryoLife, Inc. Micro Interventional Devices, Inc. (shrink)

The Public Sphere from Outside the West brings together established and emerging new voices from philosophy, literature, anthropology, history, migration studies and information technology to address the present reality of the public sphere. In the age where everyone is in the public and everything is visible, this volume creates a delay in which the internet of things, mass surveillance and social media are asked "What is/not the Public?†? The essays bring to attention the formation of geo-politically and historically distinct public (...) spheres from South Africa, India, America and Europe. Such formations are found not only in the postcolonial histories of print, photography, cinema and caricature but also those underway in the digital era, such as the Arab Spring, Occupy movements and Anonymous. Through critical engagement with philosophers such as Kant, Heidegger, Benjamin, Habermas and Arendt, the determining concepts of the Public Sphere-privacy, secrecy, reason, the people-are shown to be undergoing epistemological and practical ruptures. Demonstrating the necessity of these considerations to understand the world public that is rapidly transforming this concept in radical ways through technologies today, this is the first collection on the subject to feature an impressive range of international thinkers. Global and timely in outlook, it breaks new ground and changes our way of looking at politics in the 21st century. (shrink)

In the fight against racism, philosophy has to interrogate caste in its own histories and current decolonial consensus. Caste has been evading its interrogation as the oldest race theory and racist practice, which continue to oppress the lower-caste peoples who constitute the majority population of the Indian subcontinent. Caste and race are species of the hypophysics of man, which consecrates scaled intrinsic value in human nature through the notion of “being born as” by “being born to.” They are analogues in (...) having the same denigrate-dominate function of exploiting by including as born inferior. However, caste and race are also homologues since the hypophysics of caste has been at the origins of the hypophysics of race from at least the eighteenth century, culminating in the “Aryan doctrine” of the Nazis, now being revived. Caste was the empirical, conceptual, and textual resource for Europeans as it showed that large groups could be dominated as well as excluded through the self-designated superiority, supplied by the Brahminical texts, of the oppressing group. Rather than a colonial construct, caste is the oldest racism, which in colonial times devised new calypsologies—ways to mask itself against rising anticaste thought and politics. Postcolonial and subaltern theories disguise caste’s racism as “religion,” “culture,” and subaltern subjectivity, while some sociologists have denigrated Dalit scholarship as unacademic and emotional. The homologies of caste are still dangerously regnant today. (shrink)

This chapter contains sections titled: Introduction The Vedic heritage The Prithivi Sukta The Epics and Puranic heritage The sanctity‐of‐life principle Pollution and its prevention in Hindu scriptures Eco‐spirituality and environmental conservation.

Freud’s late works established the schema of a more or less inexorable civilizational course built around one drive—the death drive—despite his emphatic insistence on a dual structure of two drives. This schema became influential for Critical Theory and in a more subterranean way, also for decolonial thought, and has been widely invoked during the pandemic. It indicates the extent to which drive, destruction, and mastery have consolidated into a, which not only fails to be dislodged by but even informs Derrida’s (...) readings of Freud. Instead, we have to be attentive to the play of homology in Freud as of life, psyche, and civilization, as archaic inheritance. Freudian homology distinguishes itself from what Derrida called “genealogical drive.” The Freudian assumptions in this regard need to be addressed in a step beyond which works with a concept of origin—as its own interruption—that can neither comprehend nor deconstruct the concept of origin as a single and perpetually active homological power as is to be found in Freud. (shrink)

Global Biopharmaceuticals Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Get a Sample Copy of the Report at – -/- Biopharmaceuticals are complex medicines extracted or semisynthesized from biological sources using biotechnological methods. They can be sugars, proteins, nucleic acids, living cells, or tissues used for therapeutic or in vivo diagnostic purposes and are produced by means other than direct (...) extraction from a native or non-engineered biological source. -/- Drivers & Restraints -/- The global biopharmaceuticals market size stood at USD 470.80 Billion in 2023 and is projected to reach USD 799.76 Billion by 2030, exhibiting at a CAGR of 7.9% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Biopharmaceuticals Market report. -/- This report focuses on Biopharmaceuticals Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Biopharmaceuticals Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Biopharmaceuticals Market research report: -/- Pfizer Inc. (U.S.) AbbVie Inc. (U.S.) Bristol-Myers Squibb Company (U.S.) Johnson & Johnson Services, Inc. (U.S.) Bayer AG (Germany) Lilly (U.S.) Sanofi (France) Merck & Co., Inc. (U.S.) F. Hoffmann-La Roche Ltd. (Switzerland) Novartis AG (Switzerland) GSK plc (U.K.) Takeda Pharmaceutical Company Limited. (Japan). (shrink)

Global Cancer Diagnostics Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Cancer diagnostic services are useful in recognizing and distinguishing numerous types of cancer. The demand for this service is poised to surge over the coming years with an escalation of the cancer. By 2050, the number of new cancer cases across the globe is set to touch 35 million, (...) depicting a 77% rise from 20 million in 2022, cites the World Health Organization. -/- Drivers & Restraints -/- The global cancer diagnostics market size was valued at USD 15.13 billion in 2023. The market is slated to expand from USD 16.12 billion in 2024 to USD 31.00 billion by 2032, exhibiting a CAGR of 8.5% during the projection period. -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Cancer Diagnostics Market report. -/- This report focuses on Cancer Diagnostics Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cancer Diagnostics Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Cancer Diagnostics Market research report: -/- Hoffmann-La Roche Ltd (Switzerland) Thermo Fisher Scientific Inc. (U.S.) Abbott (U.S.) Illumina, Inc. (U.S.) GE Healthcare (U.S.) BD (U.S.) bioMérieux SA (France) Myriad Genetics, Inc (U.S.) Bio-Rad Laboratories, Inc. (U.S.) QIAGEN (Germany). (shrink)

Global Cellular Health Screening Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Get a Sample Copy of the Report at – -/- Also, the growing importance of healthy life expectancy (HALE) and the use of home diagnostic tests are remarkably increasing globally. As a result, there is increasing demand for cellular health screening kits and services due to greater patient (...) awareness. Moreover, home diagnostic tests are convenient for patients because it helps to save time and cost associated with visiting hospitals and clinics. -/- Drivers & Restraints -/- The growing awareness for personalized medicine across the world due to the emergence of new disease conditions increased the rate of clinical studies conducted in countries such as the U.S., the U.K., and China. This led to the adoption of cellular health screening tests for an overview of health at a cellular level. -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Cellular Health Screening Market report. -/- This report focuses on Cellular Health Screening Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cellular Health Screening Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Cellular Health Screening Market research report: -/- . (shrink)

We examined whether the N400 Event-Related Potential component would be modulated by dispositional affect during sentence processing. In this study, 33 participants read sentences manipulated by direct object type and object determiner type. We were particularly interested in sentences of the form: The connoisseur tasted thewineon the tour vs. The connoisseur tasted the #roof… We expected that processing incongruent direct objects vs. congruent objects would elicit N400 effects. Previous ERP language experiments have shown that participants in positive and negative moods (...) were differentially sensitive to semantic anomaly, resulting in different N400 effects. Presently, we ask whether individual dispositional affect scores would modulate N400 effects as shown previously. Namely, previous results showed larger N400 effects associated with happy moods and attenuated amplitudes associated with sad moods. Results revealed significant N400 effects, driven by the #roof vs. the wine, where larger amplitude differences were found for individuals showing smaller negative affect scores, thus partially replicating previous findings. We discuss our results in terms of theories of local inhibition, such that low NA promotes stronger lexico-semantic links in sentences. Finally, our results support accounts of language processing that include social and biological characteristics of individuals during real-time sentence comprehension. (shrink)

Global Neuropathic Pain Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. Novartis AG, Pfizer Inc., and Viatris Inc. are some of the leading companies that hold a noteworthy share of the global market. These players focus on enhancing their product portfolio for nerve pain management to strengthen their market positions. In July 2023, Novartis AG procured the U.S.-based, preclinical-stage biotechnology business (...) named DTx Pharma with an objective to improve its R&D to produce siRNA therapeutics for neurology indications. -/- Drivers & Restraints -/- The global neuropathic pain market size was USD 7.37 billion in 2023. The market is expected to surge from USD 7.79 billion in 2024 to USD 14.05 billion by 2032 at a CAGR of 7.7% during 2024-2032. -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Neuropathic Pain Market report. -/- This report focuses on Neuropathic Pain Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Neuropathic Pain Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- An Overview of the Impact of COVID-19 on this Market: -/- The advancement of COVID-19 has conveyed the world to a stop. We fathom that this prosperity crisis amazingly influences associations across ventures. Nevertheless, everything fortunate or unfortunate should reach a conclusion. There are a couple of organizations that are fighting and some are thriving. By and large, essentially every region is relied upon to be impacted by the pandemic. -/- We are advancing incessant endeavors to help your business support and create during COVID-19 pandemics. Considering our experience and expertise, we will offer you an impact examination of Covid episode across ventures to help you with preparing for what's to come. -/- Key players covered in the global Neuropathic Pain Market research report: -/- Almatica (U.S.) Azurity Pharmaceuticals, Inc. (U.S.) Pfizer Inc. (U.S.) Viatris Inc. (U.S.) Supernus Pharmaceuticals, Inc. (U.S.) Novartis AG (Switzerland) Accord Healthcare (U.K.) Focus Health Group (U.S.) Amneal Pharmaceuticals LLC (U.S.) Abbott (U.S.) Teva Pharmaceutical Industries Ltd. (Israel) Market Share Analysis: -/- The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. (shrink)

Global Stomach Cancer Treatment Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. -/- Stomach cancer is the fifth most common cancer in the world. According to Cancer Research U.K., 6,697 gastric carcinoma cases are diagnosed each year. Stomach cancers are classified into three types. Gastric Adenocarcinoma is the most common type of stomach cancer and accounts for 90%-95% of stomach cancer (...) cases. Gastrointestinal Stromal Tumor (GIST) and Gastric Neuroendocrine Tumors (gNET) are rare in nature. Rising incidence of cancer cases and limited drugs as first-line treatment are the major factors that have encouraged many pharmaceutical giants to conduct research for the development of novel drugs. -/- Drivers & Restraints -/- The global stomach cancer treatment market size stood at USD 2.61 Billion in 2018 and is projected to reach USD 8.20 Billion by 2026, exhibiting at a CAGR of 15.3% in the forecast period -/- This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Stomach Cancer Treatment Market report. -/- This report focuses on Stomach Cancer Treatment Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Stomach Cancer Treatment Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. -/- Competitive Strategic Window: -/- The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. -/- . (shrink)

Adoption of technology, a research topic within the Information Systems area, is usually studied at two levels: organizational level and user level. This paper examines the range of methods used for studying technology adoption issues at both these levels. The approaches were selected after conducting a review of 48 articles on technology adoption and usage, published in peer reviewed journals between 1985 and 2003. The journals reviewed include the MIS Quarterly, Information Systems Research, European Journal of Information Systems, Information Systems (...) Journal, and other relevant journals in the IS area. The findings suggest that the survey method was used predominantly when investigating the topics of user adoption and the usage of technology. In contrast, the case study method is the most widely used when examining adoption issues at the organizational level. (shrink)